Jan 22 (Reuters) - Regeneron Pharmaceuticals Inc:
* REGENERON ANNOUNCES APPROVAL OF DUPIXENTÂ® (DUPILUMAB) IN JAPAN FOR THE TREATMENT OF ATOPIC DERMATITIS
* REGENERON PHARMACEUTICALS - DUPIXENT IS BEING JOINTLY DEVELOPED BY CO, SANOFI UNDER A COLLABORATION AGREEMENT, & WILL BE COMMERCIALIZED IN JAPAN BY SANOFI Source text for Eikon: Further company coverage:
 